Navigation Links
Nobles Medical Technologies II's NobleStitch EL begins Sales in Europe
Date:5/28/2013

Fountain Valley, California (PRWEB) May 28, 2013

Dr Michael Mullen, a Consultant Cardiologist at University College Hospital London, UK and a member of the NMT2 Clinical Advisory Board performed the procedures using the latest generation of the NobleStitch.

The patients all received the procedure to suture their PFO closed without the use of a metallic implant or the need for long term anticoagulation. “The clinical benefit of PFO closure without leaving any device behind are significant, I am excited to watch the long term results of patients who have this technology versus a metal implant left in the hearts.” Said Dr. Mullen. Also present at the cases for training was Prof. Dr. Anthony Nobles, CEO of NMT2 who commented “The cases were very smooth and Dr. Mullen is such an expert that very little additional training was required, we look forward to carrying on this same success with all of our new customers”.

About Patent Foramen Ovale (PFO)
A PFO is a tunnel that exists between the left and right atrium of the heart. The tunnel, which is part of the normal fetal anatomy, should close shortly after birth. In 27% of the population the tunnel never closes. This tunnel can then allow clots and other chemicals to pass from the right to the left side of the heart freely bypassing the filter of the lungs. These clots and chemicals can cause strokes and other conditions such as severe migraines.

About the NobleStitch EL System
Nobles Medical Technologies II's NobleStitch EL is a catheter based system that allows a physician to place a suture in the PFO tunnel in the heart through a percutaneous puncture in the leg, in many cases under a local anesthetic in a catheter lab rather than an operating room. This eliminates the need for open-heart surgery or placement of a large metallic implant in the heart. The NobleStitch is not a “device” or mechanical implant it only places a simple polypropylene suture in the heart. By closing the hole or PFO, the therapy will reduce or eliminate the shunting from the right to the left side of the heart allowing the lungs to filter the clots and other chemicals from making it to the brain, potentially halting strokes and severe migraines and enabling patients to live a higher-quality life.

About Nobles Medical Technologies II
Nobles Medical Technologies II is a global structural heart company devoted to improving life through the development of its products and technologies. Nobles Medical Technologies II is focused on suture based solutions for the septum.

Visit Nobles Medical Technologies II http://www.noblesmedicaltechnology.com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10774928.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Kids Poisoned by Medical Marijuana, Study Finds
2. The analysis of medical images is improved to facilitate the study of psychotic disorders
3. DiscountMedicalSupplies.com Reaches Out to More People in Need of Low-Price Medical Supplies Through Valpak
4. Just Home Medical Debuts Updated Selection of Overbed Tables
5. Cherry Creek Medical Weight Loss Has Reached Their Goal
6. CEO of Sirtex Medical Gilman Wong Selected for Inclusion in The CEO Magazine
7. California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014
8. Many Medical Students Have Anti-Fat Bias, Study Finds
9. General Data Acquires Triangle Biomedical Sciences
10. Medical Group Practice Management in the US Industry Market Research Report Now Available from IBISWorld
11. New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... The parent company ... in employee engagement. Omaha-based C&A Industries, a national leader in staffing and ... in North America for 2017. The annual award, issued by Achievers, ...
(Date:6/28/2017)... Church, VA (PRWEB) , ... June 28, 2017 , ... ... http://www.fdanews.com/fdaeumdregs      , No matter on which side of the Atlantic devicemakers ... medical device regulations they have to follow. , In addition to the full text ...
(Date:6/28/2017)... ... June 28, 2017 , ... Eating disorders have the highest mortality ... at least one person dies as a direct result from an eating disorder in ... qualified treatment providers. The iaedp Foundation meets this challenge by offering what has become ...
(Date:6/28/2017)... ... June 28, 2017 , ... American Farmer proudly announces the participation of ... winning television series, scheduled to broadcast fourth quarter 2017. American Farmer airs Tuesdays at ... supplier of garden pea seed. As demand grew, the small company located in Moscow, ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... insurance management and financial planning assistance to clients in southern Montana, is announcing ... offered by Zoo Montana. , The outreach programs offered by Zoo Montana provide ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... of two Phase 2 trials of its RSV F protein ... child bearing age have been published in the journal ... have been shared in prior scientific conferences). The Company previously ... April 2014. Novavax is developing the RSV F Vaccine with ...
(Date:6/2/2017)... Mass. , June 2, 2017  NxStage Medical, ... renal care, today announced new findings demonstrating positive biochemical ... ® System One™. The data will be presented ... in Madrid, Spain . ... to Improve Home Dialysis Network in Europe ...
(Date:5/29/2017)...  Cellect Biotechnology Ltd. (NASDAQ: APOP ; TASE: ... functional selection of stem cells, today provided a corporate ... ended March 31 st , 2017. ... first quarter of 2017," said Dr. Shai Yarkoni, Chief ... treatment of the first blood cancer patient in the ...
Breaking Medicine Technology: